Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins

Publisher Website
Google Scholar
Abstract
Studies performed with animals suggest neurosteroid involvement in neuroprotection. However in humans, the role of neurosteroidogenesis in the regulation of degenerative processes is unknown. To determine whether cellular factors intervening in degenerative mechanisms may interfere with the process of neurosteroidogenesis in humans, we combined pulse‐chase experiments with HPLC and continuous flow scintillation detection to compare neurosteroid production in normal and transfected SH‐SY5Y cells with key proteins involved in Alzheimer's disease (AD). Microscope analyses revealed that cell morphology was unchanged in stably transfected SH‐SY5Y cells overexpressing human native tau (hTau40), mutant tau (P301L), and wild‐type amyloid precursor protein (APPwt) compared to controls. Biochemical investigations showed that hTau40 enhanced progesterone (PROG), 17OHPROG, testosterone, and 3α‐androstanediol neosynthesis from pregnenolone. In contrast, tau with the pathogenic P301L mutation was devoid of action on neurosteroidogenesis. Overexpression of APPwt inhibited PROG formation, did not affect 17OHPROG and testosterone, but increased 3α‐androstanediol and estradiol synthesis. Extracellular treatment of control cells with aggregated amyloid peptide mimicked the action of APPwt expression on PROG but not on 3α‐androstanediol and estradiol production. Moreover, PROG biosynthesis in APPwt cells was up‐regulated in the presence of a γ‐secretase inhibitor. Our results provide the first evidence for the regulation of neurosteroid biosynthesis by key proteins involved in the etiology of AD. The data suggest that pathogenic factors may induce neurodegeneration in humans through the reduction of the synthesis of endogenous neuroprotective neurosteroids in nerve cells. © 2006 Wiley Periodicals, Inc. J Neurobiol, 2006